Among different statins, simvastatin has been shown to demonstrate better outcomes in patients with breast cancer (Ahern et al., 2011), thus it was chosen to investigate the dose and time dependent effects of statins on PTTG1 expression in MDA-MB-231 cells. Here, PTTG1 is linked to breast carcinoma.